Detalles de la búsqueda
1.
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Oncotarget
; 8(27): 43653-43661, 2017 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28525389
Resultados
1 -
1
de 1
1
Próxima >
>>